missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CRMP1 Rabbit anti-Human, Rat, Clone: 1U7K3, Novus Biologicals™
  7. 18310597

CRMP1 Rabbit anti-Human, Rat, Clone: 1U7K3, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Bio-Techne NBP3-16120-20UL

1196.00 DKK valid until 2025-03-28
Use promo code "25306" to get your promotional price.

 View more versions of this product

Product Code. 18310597

  • 1495.00 DKK / 20µL

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

CRMP1 Monoclonal antibody specifically detects CRMP1 in Human, Rat samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CRMP1
Monoclonal
Unconjugated
collapsin response mediator protein 1DRP1, CRMP-1, dihydropyrimidinase-like 1, dihydropyrimidinase-related protein 1, DPYSL1DRP-1dihydropyrimidinase related protein-1, ULIP3, ULIP-3, Unc-33-like phosphoprotein 3
A synthetic peptide corresponding to a sequence within amino acids 450-550 of human CRMP1 (Q14194).
20 μg
Neuroscience
1400
Store at -20°C. Avoid freeze-thaw cycles.
IgG
Western Blot
1U7K3
PBS, 0.05% BSA, 50% glycerol, pH7.3
Rabbit
Affinity purified
RUO
Primary
Human, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.